Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer

被引：0
|
作者：
Schabath, Matthew [1 ]
Dalvi, Tapashi [2 ]
Dai, Hongyue [3 ]
Crim, Alan [3 ]
Midha, Anita [4 ]
Shire, Norah [2 ]
Walker, Jill
Greenawalt, Danielle [5 ]
Lawrence, David
Rigas, James [6 ]
Brody, Robert [2 ]
Potter, Danielle [2 ]
Kumar, Naveen [3 ]
Huntsman, Shane [3 ]
Grays, Jhanelle [7 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol, Tampa, FL USA
[2] Astrazeneca, Gaithersburg, MD USA
[3] M2Gen, Tampa, FL USA
[4] Astrazeneca, Chester, Cheshire, England
[5] Astrazeneca, Waltham, MA USA
[6] Astrazeneca, Hanover, NH USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
PD-L1; lung cancer; epidemiology; Immunotherapy;
D O I：
10.1016/j.jtho.2016.11.566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-042
引用
收藏
页码：S475 / S476
页数：2
相关论文
共 50 条
  • [1] Expression analysis of programmed cell death 1 ligand 1 (PD-L1) in patients with non-small cell lung cancer
    Peng, Nanqiu
    Qin, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (01): : 1 - 5
  • [2] Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Minuti, G.
    Gallo, M.
    De Luca, A.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2389 - S2389
  • [3] A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer
    Schabath, Matthew B.
    Dalvi, Tapashi B.
    Dai, Hongyue A.
    Crim, Alan L.
    Midha, Anita
    Shire, Norah
    Gimbrone, Nicholas T.
    Walker, Jill
    Greenawalt, Danielle M.
    Lawrence, David
    Rigas, James R.
    Brody, Robert
    Potter, Danielle
    Kumar, Naveen S.
    Huntsman, Shane A.
    Gray, Jhanelle E.
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9469 - 9481
  • [4] Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer
    Sepesi, Boris
    Cuentas, Edwin Parra
    Canales, Jaime Rodriguez
    Behrens, Carmen
    Correa, Arlene M.
    Vaporciyan, Ara
    Weissferdt, Annikka
    Kalhor, Neda
    Moran, Cesar
    Swisher, Stephen
    Wistuba, Ignacio
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (03) : 408 - 415
  • [5] Programmed Death Ligand 1 (PD-L1) Expression in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    D'Arcangelo, M.
    Puccetti, M.
    Bravaccini, S.
    D'Incecco, A.
    Ligorio, C.
    Terracciano, L.
    Damiani, S.
    Ravaioli, S.
    Tumedei, M. M.
    Bennati, C.
    Minuti, G.
    Vecchiarelli, S.
    Landi, L.
    Incarbone, M.
    Milesi, M.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2390 - S2390
  • [6] Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence
    Lacour, Max
    Hiltbrunner, Stefanie
    Lee, Seok-Yun
    Soltermann, Alex
    Rushing, Elisabeth Jane
    Soldini, Davide
    Weder, Walter
    Curioni-Fontecedro, Alessandra
    CLINICAL LUNG CANCER, 2019, 20 (05) : 391 - 396
  • [7] Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer
    Pan, Yunjian
    Zheng, Difan
    Li, Yuan
    Cai, Xu
    Zheng, Zongli
    Jin, Yan
    Hu, Haichuan
    Cheng, Chao
    Shen, Lei
    Wang, Jian
    Ji, Hongbin
    Sun, Yihua
    Zhou, Xiaoyan
    Chen, Haiquan
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2579 - 2586
  • [8] Programmed cell death ligand-1(PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
    Mari Mino-Kenudson
    Cancer Biology & Medicine, 2016, (02) : 157 - 170
  • [9] Prevalence of programmed cell death ligand 1 (PD-L1) Expression among Tumor Samples from Iraqi Patients with Non-Small Cell Lung Cancer
    Yahya, Alaa Qasim
    Alhamadani, Zina A. Rajab
    Ahmed, Samir Z.
    Hussain, Ahmad Fawzi
    ADVANCEMENTS IN LIFE SCIENCES, 2025, 12 (01): : 114 - 119
  • [10] Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer
    Lamberti, G.
    Spurr, L. F.
    Li, Y.
    Ricciuti, B.
    Recondo, G.
    Umeton, R.
    Nishino, M.
    Sholl, L. M.
    Meyerson, M. L.
    Cherniack, A. D.
    Awad, M. M.
    ANNALS OF ONCOLOGY, 2020, 31 (06) : 807 - 814
12345